Skip to main content

Animations

MJFF Publications

5821 - 5830 of 8715 Results
Title
Year
  • Year
  • 2021
  • 2018
  • 2020
  • 2018
  • 2019
  • 2024
  • 2025
  • 2020
  • 2024
  • 2020
  • Summary Details
    OPEN
    Title: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab374
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-018-1947-3
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in Mice
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.05.047
    Citation Count: 18
  • Summary Details
    OPEN
    Title: PP1 Phosphatase Complexes: Undruggable No Longer
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, elsevier-specific: oa user license
    DOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27659
    Citation Count: 310
  • Summary Details
    RESTRICTED
    Title: Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awae069
    Citation Count: 24
  • Summary Details
    OPEN
    Title: A meta-analysis of genetic variant pathogenicity and sex differences in UBQLN2-linked amyotrophic lateral sclerosis and frontotemporal dementia
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107127
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Netrin‐1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson’s disease features
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2020105537
    Citation Count: 62
  • Summary Details
    OPEN
    Title: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neurons
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49256-3
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8
    Citation Count: 114
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.